Abstract

Background: Cannabis is the third most consumed drug worldwide. Thus, healthcare providers should be able to identify users who are in need for an intervention. This study aims to explore the relationship of acute, chronic, and early exposure (AE, CE, and EE) to cannabis with cognitive and behavioral harms (CBH), as a first step toward defining risky cannabis use criteria.Methods: Adults living in Spain who used cannabis at least once during the last year answered an online survey about cannabis use and health-related harms. Cannabis use was assessed in five dimensions: quantity on use days during the last 30 days (AE), frequency of use in the last month (AE), years of regular use (YRCU) (CE), age of first use (AOf) (EE), and age of onset of regular use (AOr) (EE). CBH indicators included validated instruments and custom-made items. Pearson correlations were calculated for continuous variables, and Student's t-tests for independent samples were calculated for categorical variables. Effect sizes were calculated for each of the five dimensions of use (Cohen's d or r Pearson correlation) and harm outcome. Classification and Regression Trees (CART) analyses were performed for those dependent variables (harms) significantly associated with at least two dimensions of cannabis use patterns. Lastly, logistic binary analyses were conducted for each harm outcome.Results: The mean age of participants was 26.2 years old [standard deviation (SD) 8.5]. Out of 2,124 respondents, 1,606 (75.6%) reported at least one harm outcome (mean 1.8 and SD 1.5). In our sample, using cannabis on 3 out of 4 days was associated with an 8-fold probability of scoring 4+ on the Severity Dependence Scale (OR 8.33, 95% CI 4.91–14.16, p <0.001), which is indicative of a cannabis use disorder. Also, a start of regular cannabis use before the age of 25 combined with using cannabis at least once per month was associated with a higher probability of risky alcohol use (OR 1.33, 95% CI 1.12–1.57, p = 0.001). Besides, a start of regular cannabis use before the age of 18 combined with a period of regular use of at least 7.5 years was associated with a higher probability of reporting a motor vehicle accident (OR 1.81, 95% CI 1.41–2.32, p < 0.0001). Results were ambiguous regarding the role that age of first use and milligrams of THC per day of use might play regarding cannabis-related harms.Conclusions: The relationship among AE, CE, and EE with CBH indicators is a complex phenomenon that deserves further studies. The pattern of cannabis use should be carefully and widely evaluated—(not just including frequency but also other dimensions of pattern of use)—in research (preferably in longitudinal studies) to assess cannabis-related harms.

Highlights

  • Cannabis is the third most consumed drug worldwide

  • Using the data obtained in a survey that was answered by a sample of 2,124 Spanish adult cannabis users, mostly men in their 20’s with university degrees, we aim to explore the relationship among five dimensions of cannabis use—grouped as acute exposure, early exposure, and chronic exposure—and 12 indicators of cognitive and behavioral related harms

  • Classification and Regression Trees (CART) analyses identified a subgroup of higher risk of SDS >4 in those who used cannabis at least 28.5 days per month (61.9 vs. 33.6% of whole subsample, see Figure 7)

Read more

Summary

Introduction

Cannabis is the third most consumed drug worldwide. healthcare providers should be able to identify users who are in need for an intervention. Cannabis is the third most prevalent psychoactive substance used worldwide. There were an estimated 192 million past-year users of cannabis in 2018, corresponding to 3.9% of the global population aged 15–64 [1]. In Europe, 90.2 million adults (aged 15–64), or 27.4% of this age group, reported lifetime cannabis use. Among this whole group, 7.6% reported use during the last year. Previous literature has extensively documented multiple health-related harms associated with cannabis use. Besides several somatic harms such as respiratory adverse events, cancer, cardiovascular outcomes, and gastrointestinal disorders, the deleterious consequences of cannabis use on mental health, cognition, and behavior are well-documented [6, 7]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call